Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This early-phase trial tested a combination of two drugs (TQB2928 injection and anlotinib capsules) in 20 adults with advanced bone cancer (osteosarcoma) or other solid tumors that had returned or spread. The goal was to see if the combination could shrink tumors or delay cancer …

This study tested a new pill called TQB3909 in 19 adults with mantle cell lymphoma that had returned or stopped responding to other treatments. The main goal was to find a safe dose and check for side effects. The trial was stopped early, so results are limited.

This early-stage study tested the safety of a new drug called AP026 in healthy adults. The trial was stopped before completion, so we don't know if the drug works for type 2 diabetes. The main goal was to check for side effects and how the body processes the drug.